DRG Stimulation: Targeted Relief for Stubborn Foot and Groin Pain

DRG Stimulation: Targeted Relief for Stubborn Foot and Groin Pain

For individuals living with chronic, focal nerve pain in hard-to-reach areas—such as the foot, ankle, knee, or groin—traditional spinal cord stimulation (SCS) does not always provide adequate coverage. Dorsal Root Ganglion (DRG) Stimulation offers a specialized neuromodulation therapy engineered specifically to target isolated, focal pain sites.

By placing leads over the nerve root structure responsible for specific lower-body zones, DRG stimulation delivers precise electrical signals to interrupt pain before it reaches the central nervous system.

Understanding the Dorsal Root Ganglion

The Dorsal Root Ganglion is a cluster of sensory nerve cell bodies located at each level of the spine where nerve roots branch off toward the body.

Because the DRG acts as a primary “traffic gateway” regulating sensory signals traveling from specific peripheral regions—like the groin, hip, knee, or foot—to the spinal cord, it serves as an ideal target for localized pain control. Stimulating the DRG directly prevents painful signals originating in isolated body parts from reaching the brain.

Who Is a Candidate for DRG Stimulation?

DRG stimulation is particularly effective for focal chronic pain conditions that remain non-responsive to conservative therapies, nerve blocks, or prior spine surgeries:

• Complex Regional Pain Syndrome (CRPS): Focal CRPS isolated to a single foot, ankle, or knee.
• Post-Surgical Groin Pain: Chronic nerve entrapment or pain following hernia repair or hip procedures.
• Phantom Limb Pain or Post-Amputation Pain: Targeted pain in a specific lower extremity area.
• Refractory Neuropathy: Pain isolated to specific nerve dermatomes in the lower extremities.

The Trial and Implantation Process

Like traditional spinal cord stimulation, DRG stimulation includes a temporary 5- to 7-day trial period:

1. Trial Phase: Thin micro-leads are guided under fluoroscopy directly onto the target dorsal root ganglia and connected to an external trial controller. If pain decreases by 50% or more during normal daily activity, the trial is deemed successful.
2. Permanent Implantation: A small, rechargeable generator is placed beneath the skin in the upper buttock or lower abdomen, connected to slim internal leads for discrete, long-term pain management.

• Book Online: Visit igeaneuro.com to request a comprehensive diagnostic consultation with our pain management team.
• Call Our Team Today: Speak directly with our dedicated patient care coordinators at (866) 467-1770.